Sort
21,453 grants matching “tuberculosis”
Assessing the efficacy of BCG vaccination in a pre-clinical model of SARS-CoV-2 infection
$239,521Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Developing Intravesical Liposomes for Interstitial Cystitis
$239,516Jonathan H Kaufman · Lipella Pharmaceuticals, Inc. · R42 · FY2011 · DK
The Role of SP-A in Pulmonary Host Defense
$239,400Vanderbilt University · R01 · FY2002 · AI
Regulation of CD4 T cell responses by IFN gamma during tuberculosis infection
$239,385Gary M. Winslow · Wadsworth Center · R21 · FY2010 · AI
IL-10 as a host modifier of PZA activity
$239,375Joanne Turner · Texas Biomedical Research Institute · R21 · FY2017 · AI
Discovering novel antifungal agents via multi-species profiling of a structurally and stereochemically diverse, well-validated compound library
$239,354Partha Pratim Nag · Broad Institute, Inc. · R21 · FY2019 · AI
Antigen Capture Assays for Rapid Tuberculosis Diagnosis
$239,299Weill Medical College Of Cornell Univ · R21 · FY2004 · AI
Riboflavin biosynthesis and utilization in Mycobacterium tuberculosis
$239,250Jessica Chuang Seeliger · State University New York Stony Brook · R21 · FY2024 · AI
Safe mucosal vaccines
$239,250Terry D. Connell · State University Of New York At Buffalo · R21 · FY2016 · DE
Novel Indigoid Anti-Tuberculosis Agents
$239,250Larry Klein · University Of Illinois At Chicago · R21 · FY2013 · AI
Iron-dependence of clofazimine activity in mycobacteria
$239,247Martin Inua Voskuil · University Of Colorado Denver · R21 · FY2019 · AI
Maltoheptaose based nanotherapeutics for multidrug resistant bacterial infection
$239,175Mingdi Yan · University Of Massachusetts Lowell · R21 · FY2015 · AI
Targets for short-course TB therapy
$239,119Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · R21 · FY2008 · AI
Project C: Transmission II Elimination
$239,106William J Moss · Johns Hopkins University · U19 · FY2018 · AI
BU Summer Institute for Research Education in Biostatistics and Data Science
$239,101Helen E. Jenkins · Boston University Medical Campus · R25 · FY2023 · AI
Controlling renal oxidative stress in CKD via targeting FGF23 bioactivity
$239,040Rafiou Agoro · Jackson Laboratory · R00 · FY2024 · DK
HIV AIDS and Opportunistic Infections
$239,020Vinayaka R Prasad · Albert Einstein College Of Medicine · T32 · FY2006 · AI
MCP-1 and susceptibility to active tuberculosis
$238,855Dana-Farber Cancer Institute · R21 · FY2002 · HL
The first commercial rapid diagnostic test to detect Paragonimus infections
$238,810Richard Kimo Baldwin · Nanocomposix, Inc. · R41 · FY2019 · AI
Tracking the hierarchical secretion of ESX-1 substrates through the mycobacterial cell envelope
$238,787Jessica Chuang Seeliger · State University New York Stony Brook · R21 · FY2025 · AI
Pseudopteroxazole and Related Antitubercular Agents
$238,775Michael Harmata · University Of Missouri-Columbia · R01 · FY2007 · AI
Isoprenoid Biosynthesis: A Target for Drugs Against Category A-C Pathogens
$238,746Dean C Crick · Colorado State University · U54 · FY2008 · AI
Tulane National Primate Research Center
$238,692Lee Hamm · Tulane University Of Louisiana · P51 · FY2015 · OD
A multi-disciplinary approach to the identification of host metabolic determinan
$238,657Megan Murray · Brigham And Women'S Hospital · U19 · FY2015 · AI
Mechanism of anti-folate resistance in mycobacteria
$238,650Endang Purwantini · Virginia Polytechnic Inst And St Univ · R21 · FY2020 · AI